Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 9,10-anthracenedicarboxaldehyde Bis(4,5-dihydro-1h-imidazol-2-yl)hydrazone
2. Bisantrene Dihydrochloride
3. Cl 216942
4. Cl216,942
5. Nsc 337766
1. 78186-34-2
2. Bisantrene [inn]
3. Bisantrenum [inn-latin]
4. Bisantreno [inn-spanish]
5. Nsc 337766
6. Bisantrene Hydrochloride
7. Brn 0966309
8. Bisantrenum
9. Cl 216942
10. Chembl25336
11. Unii-39c34m111k
12. 39c34m111k
13. Bisantrene Hcl
14. N-[(e)-[10-[(e)-(4,5-dihydro-1h-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1h-imidazol-2-amine
15. 9,10-anthracendicarbaldehyde Bis(2-imidazolin-2-ylhydrazon)
16. 9,10-bis((2-(4,5-dihydro-1h-imidazol-2-yl)hydrazono)methyl)anthracene
17. 9,10-anthracenedicarboxaldehyde, Bis((4,5-dihydro-1h-imidazol-2-yl)hydrazone)
18. Nsc-337766
19. 9,10-anthracenedicarboxaldehyde Bis(2-imidazolin-2-ylhydrazone)
20. 9,10-bis(2-(4,5-dihydro-1h-imidazol-2-yl)hydrazono)methyl)anthracene
21. C22h22n8.2clh
22. C22-h22-n8.2cl-h
23. Nsc337766
24. 71439-68-4
25. 9,10-anthracenedicarboxaldehyde, Bis((4,5-dihydro-1h-imidazol-2-yl)hydrazone)-
26. Cl216942
27. Bisantrene [mi]
28. Cl216,942
29. 9,10-anthracenedicarboxaldehyde, Bis(4,5-dihydro-1h-imidazol-2-yl Hydrazone),dihydrochloride
30. Bisantrene [who-dd]
31. Schembl8906393
32. 9,10-anthracenedicarboxaldehyde Bis[(4,5-dihydro-1h-imidazol-2-yl)hydrazone]
33. 9,10-bis((e)-(2-(4,5-dihydro-1h-imidazol-2-yl)hydrazono)methyl)anthracene
34. Ex-a2382
35. Bdbm50060768
36. Ccg-35603
37. 9,10-anthracenedicarboxaldehyde Bis(4,5-dihydro-1h-imidazol-2-yl)hydrazone
38. Cs-6132
39. Ac-35847
40. As-75775
41. Ls-20289
42. N-[(e)-[10-[(e)-(4,5-dihydro-1h-imidazol-2-ylhydrazono)methyl]-9-anthryl]methyleneamino]-4,5-dihydro-1h-imidazol-2-amine
43. Hy-100875
44. Brd-k64298650-300-01-5
45. 9,10-anthracenedicarboxaldehyde Bis(2-imidazolin-2-yl-hydrazone)
46. 9,10-anthracenedicarbaldehyde Bis(4,5-dihydro-1h-imidazol-2-ylhydrazone)
47. Anthracene-9,10 Bis-carbaldehyde 4,5-dihydro-1h-imidazol-2-ylhydrazone
48. 9,10-anthracenedicarboxaldehyde Bis[(4,5-dihydro-1h-imidazol-2yl)hydrazone)
49. 9,10-anthracenedicarboxaldehyde, Bis(4,5-dihydro-1h-imidazol-2-ylhydrazone),dihydrochloride
50. N-anthracen-9-yl Methylene N''-[(bis)4,5-dihydro-1h-imidazole-2-yl)-hydrazine
51. N-anthracen-bis-9,10-ylmethylene-n''-(4,5-dihydro-1h-imidazol-2-yl)-hydrazine(bisantrene)
52. 10-imino(4,5-dihydro-1h-2-imidazolamine)methyl-9-anthrylmethan-(4,5-dihydro-1h-2-imidazolamine)imine
53. X N-4,5-dihydro-1h-2-imidazolamine-10-iminomethyl-9-anthrylmethanimine-4,5-dihydro-1h-2-imidazolamine (bisantrene)
| Molecular Weight | 398.5 g/mol |
|---|---|
| Molecular Formula | C22H22N8 |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 97.6 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 630 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antibiotics, Antineoplastic
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)
ABOUT THIS PAGE
18
PharmaCompass offers a list of Bisantrene API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bisantrene manufacturer or Bisantrene supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bisantrene manufacturer or Bisantrene supplier.
PharmaCompass also assists you with knowing the Bisantrene API Price utilized in the formulation of products. Bisantrene API Price is not always fixed or binding as the Bisantrene Price is obtained through a variety of data sources. The Bisantrene Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A C22-H22-N8.2Cl-H manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of C22-H22-N8.2Cl-H, including repackagers and relabelers. The FDA regulates C22-H22-N8.2Cl-H manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. C22-H22-N8.2Cl-H API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A C22-H22-N8.2Cl-H supplier is an individual or a company that provides C22-H22-N8.2Cl-H active pharmaceutical ingredient (API) or C22-H22-N8.2Cl-H finished formulations upon request. The C22-H22-N8.2Cl-H suppliers may include C22-H22-N8.2Cl-H API manufacturers, exporters, distributors and traders.
C22-H22-N8.2Cl-H Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of C22-H22-N8.2Cl-H GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right C22-H22-N8.2Cl-H GMP manufacturer or C22-H22-N8.2Cl-H GMP API supplier for your needs.
A C22-H22-N8.2Cl-H CoA (Certificate of Analysis) is a formal document that attests to C22-H22-N8.2Cl-H's compliance with C22-H22-N8.2Cl-H specifications and serves as a tool for batch-level quality control.
C22-H22-N8.2Cl-H CoA mostly includes findings from lab analyses of a specific batch. For each C22-H22-N8.2Cl-H CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
C22-H22-N8.2Cl-H may be tested according to a variety of international standards, such as European Pharmacopoeia (C22-H22-N8.2Cl-H EP), C22-H22-N8.2Cl-H JP (Japanese Pharmacopeia) and the US Pharmacopoeia (C22-H22-N8.2Cl-H USP).
